Search results
Results from the WOW.Com Content Network
SoFi has a price-to-book ratio of 2.8, while Bank of America and Wells Fargo have much lower ratios of 1.3 and 1.5, respectively. Yet SoFi doesn't look too expensive relative to its growth potential.
As of this writing, SoFi stock trades at a forward, 1-year price-to-earnings ratio of 65. That's not cheap, but for a growth stock, it could be a justified premium. That's not cheap, but for a ...
With shares of SoFi trading at less than $8, I see SoFi as Wood's best stock under $10. A new spin on financial services Banking, opening a brokerage account , and buying insurance are some of the ...
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. [2] It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Meanwhile, the average defense stock today has an EV/S of 2.2 and a P/S of 1.8. Compared to others in the industry, Leidos' stock looks relatively cheap. Leidos also looks attractive when ...
SoFi Technologies (NASDAQ: SOFI) stock tumbled 12.5% through 9:45 a.m. ET Tuesday despite beating on top and bottom lines in its earnings report this morning.. Heading into earnings, analysts ...